Li Laboratory

Selected Publications

Meng X, Vander Ark A, Lee P, Hostetter G, Bhowmick NA, Matrisian LM, Williams BO, Miranti CK, Li X. 2016. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis. Oncogene. 35:2370–2378.      PubMed

Banarjee J, Mishra R, Li X, Jackson RS 2nd, Sharma A, Bhowmick NA. 2014. A reciprocal role of prostate cancer on stromal DNA damage. Oncogene 33(41):4924–4931       PubMed     Article

Ganguly SS, Li X, Miranti CK.  2014.  The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.  Front Oncol 4: 364.       PubMed

Li X, Sterling JA, Fan KH, Vessella RL, Shyr Y, Hayward SW, Matrisian LM, Bhowmick NA.  2012.  Loss of TGF-beta responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.  Mol Cancer Res 10(4):494–503.     PubMed

Ge L, Smail M, Meng W, Shyr Y, Ye F, Fan KH, Li X, Zhou HM, Bhowmick NA.  2011.  Yes-associated protein expression in head and neck squamous cell carcinoma nodal metastasis.  PLoS One 6(11):e27529.     PubMed     Article

Kiskowski MA, Jackson RS 2nd, Banerjee J, Li X, Kang M, Iturregui JM, Franco OE, Hayward SW, Bhowmick NA.  2011.  Role for stromal heterogeneity in prostate tumorigenesis.  Cancer Res 71(10):3459–3470.     PubMed     Article

Li X, Martinez-Ferrer M, Botta V, Uwamariya C, Banerjee J, Bhowmick NA.  2011. Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.  Oncogene 30(2):167–177.      PubMed

Placencio VR, Li X, Sherrill TP, Fritz G, Bhowmick NA. 2010. Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth. PLoS One 5(9): e12920.      PubMed     Article

Li X, Wang Y, Sharif-Afshar AR, Uwamariya C, Yi A, Ishii K, Hayward SW, Matusik RJ, Bhowmick NA. 2009. Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling. Differentiation 77(1): 95–102.     PubMed

Li X, Placencio V, Iturregui JM, Uwamariya C, Sharif-Afshar AR, Koyama T, Hayward SW, Bhowmick NA. 2008.  Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis. Oncogene 27(56): 7118–7130.     PubMed     Article

Placencio VR, Sharif-Afshar AR, Li X, Huang H, Uwamariya C, Neilson EG, Shen MM, Matusik RJ, Hayward SW, Bhowmick NA. 2008. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.  Cancer Res 68(12): 4709–4718.      PubMed   Article

Li X, Kakkad B, Ong DE.  2004.  Estrogen directly induces expression of retinoic acid biosynthetic enzymes, compartmentalized between the epithelium and underlying stromal cells in rat uterus. Endocrinology 145(10): 4756–62.     PubMed     Article

Li X and Ong DE. 2003. Cellular retinoic acid-binding protein II gene expression is directly induced by estrogen, but not retinoic acid, in rat uterus.  Journal Biol Chem 278(37): 35819–35825.     PubMed     Article

Li X, Zhi-jie X, Piao Y. 2002. Transforming growth factor β1 and epidermal growth factor decrease the expression of 17β-hydroxysteroid dehydrogenase type 2 in endometrial carcinoma cells. Chinese Science Bulletin 47:43–46.     Article

Li X, Li H, Xiao ZJ, Piao YS. 2002. Divergent effects of retinoic acids on the expression of ERalpha and 17beta-hydroxysteroid dehydrogenase type 2 in endometrial carcinoma cells (RL 95-2).  J Clin Endocrinol Metab 87(2):640–649.     PubMed     Article

Li, X.-H.W., Juan; Lin, Ling; Gu, Hai-ming; Tao, Yan-mei; Zhang, Zu-xuan.  1997. Inhibition effect of IM-94 on cancer cells.  Journal of Nanjing University 33: 311-315.